This memo provides an update on the House Energy and Commerce Committee’s 21st Century Cures initiative, which has undergone substantial revision since the release of its first legislative draft in January 2015. Read the full memo here.
NAMD recently released a memo addressing recommendations from the HHS Office of Inspector General (OIG) in response to audits and reviews of Medicaid Personal Care Services programs (PCS). Read the full memo here.
NAMD sent a letter to the Health Resources and Services Administration (HRSA) and the Centers for Medicare and Medicaid Services (CMS) to share our recent white paper discussing operational challenges in Medicaid’s interaction with the 340B drug discount program. The white paper is available here. Read the full letter here.
This NAMD working paper describes the challenges confronted by Medicaid programs in their interactions with the 340B drug discount program, including inconsistent guidance from federal agencies, the growth of contract pharmacy arrangements, and issues with Medicaid managed care programs. The paper also offers several recommendations to address the identified challenges. Read the full paper here.
The National Association of Medicaid Directors sent a letter to the leaders of the House Energy and Commerce Committee regarding the impact to the Medicaid program from federal legislative efforts to incentivize and expedite high-cost cure-like pharmaceutical treatments and devices. Read the full letter here.
On March 30th, NAMD released Perspectives on Innovation: A State Medicaid Approach to Evaluation. The paper describes the critical questions that state Medicaid programs ask themselves when evaluating the success of payment and delivery system reform – namely whether the reform is improving health outcomes relative to what preceded it, and whether there is a […]
The National Association of Medicaid Directors released a public memo which seeks to inform ongoing congressional discussions to ensure appropriate access to high quality, coordinated services for children with complex care needs. Read the full memo here.
The National Association of Medicaid Directors submitted a letter to the Centers for Medicare and Medicaid Services Acting Administrator Slavitt. The letter acknowledges progress made to improve Medicaid and Exchange interactions and calls for additional steps to improve the beneficiary experience and efficiency of operations. Read the full letter here.
NAMD submitted comments to the Centers for Medicare and Medicaid Services in response to the Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter. NAMD urges CMS to expedite action to better support a viable delivery system for the Medicare-Medicaid dual eligible population. Read the full letter here.
NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the draft criteria for the state-certified community behavioral health clinic demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The letter focuses on the need to finalize a CCBHC framework that is flexible enough to support […]